Prostate cancer is the most common non-dermatological cancer in men in the Western world. During the last 2 decades, the widespread use of early detection programs based-on prostate-specific antigen (PSA) screening has resulted in an increase of diagnosed prostate cancer. Screening of prostate cancer has resulted in a change of patient characteristics presenting with localized prostate cancer. Nowedays, men diagnosed with this disease are at a younger age, have less comorbidities and a longer life expectancy. For patients with organ confined disease several treatment alternatives are available: active surveillance, brachytherapie, external beam radiation and radical prostatectomy. Radical prostatectomy is considered the standard for long-term cure in patients with a life expectancy of more than 10 years. Along with extended life expectancy, there is a need for better functional outcomes, including sexual function and urinary continence. Open radical prostatectomy (RP) was first described in 1904 bij HH Young.

, , , , ,
The production of this thesis was financially sponsored by: Wellspect HealthCare, Ipsen Farmaceutica B.V., Porges, Pfizer B.V., Ferring pharmaceuticals, Astellas Pharma B.V., Pohl Boskamp, Goodlife.
C.H. Bangma (Chris) , J.L.H.R. Bosch (Ruud)
Erasmus University Rotterdam
hdl.handle.net/1765/38474
Erasmus MC: University Medical Center Rotterdam

Dubbelman, Y. (2013, January 11). Functional Outcome of Radical Retropubic Prostatectomy: Sexual function and urinary continence. Retrieved from http://hdl.handle.net/1765/38474